Literature DB >> 1948082

Receptor-induced conformation change of the immunosuppressant cyclosporin A.

K Wüthrich1, B von Freyberg, C Weber, G Wider, R Traber, H Widmer, W Braun.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1948082     DOI： 10.1126/science.1948082

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  10 in total

Review 1.  A review of protein-small molecule docking methods.

Authors:  R D Taylor; P J Jewsbury; J W Essex
Journal:  J Comput Aided Mol Des       Date:  2002-03       Impact factor: 3.686

2.  1H and 13C-NMR and molecular dynamics studies of cyclosporin a interacting with magnesium(II) or cerium(III) in acetonitrile. Conformational changes and cis-trans conversion of peptide bonds.

Authors:  Francesca Bernardi; Elena Gaggelli; Elena Molteni; Elena Porciatti; Daniela Valensin; Gianni Valensin
Journal:  Biophys J       Date:  2005-11-18       Impact factor: 4.033

3.  Analysis of cyclic and acyclic nicotinic cholinergic agonists using radioligand binding, single channel recording, and nuclear magnetic resonance spectroscopy.

Authors:  K A McGroddy; A A Carter; M M Tubbert; R E Oswald
Journal:  Biophys J       Date:  1993-02       Impact factor: 4.033

4.  The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811.

Authors:  T Dorfman; H G Göttlinger
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

Review 5.  Molecular aspects of cyclophilins mediating therapeutic actions of their ligands.

Authors:  Andrzej Galat; Jacqueline Bua
Journal:  Cell Mol Life Sci       Date:  2010-07-04       Impact factor: 9.261

6.  Cyclophilin binding to the human immunodeficiency virus type 1 Gag polyprotein is mimicked by an anti-cyclosporine antibody.

Authors:  E K Franke; B X Chen; I Tatsis; A Diamanduros; B F Erlanger; J Luban
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

Review 7.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

8.  New immunosuppressive drugs: needs in and applications to pediatric transplantation.

Authors:  B D Kahan
Journal:  Eur J Pediatr       Date:  1992       Impact factor: 3.183

9.  Modeling conformational changes in cyclosporin A.

Authors:  M F O'Donohue; A W Burgess; M D Walkinshaw; H R Treutlein
Journal:  Protein Sci       Date:  1995-10       Impact factor: 6.725

10.  Determination of the NMR solution structure of the cyclophilin A-cyclosporin A complex.

Authors:  C Spitzfaden; W Braun; G Wider; H Widmer; K Wüthrich
Journal:  J Biomol NMR       Date:  1994-07       Impact factor: 2.835
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.